To check the application details, please click below.
FUNDINNO project page
https://fundinno.com/projects/211
Providing pain-free pleasure and happiness to people around the world through "needle-free syringes
(Head office: Toyama City, Toyama Prefecture; Representative: Masayoshi Fukushima) is aiming to free patients from pain and fear of needles and eliminate medical accidents, infections, and infectious waste with its Injex50, a needle-free jet injection system that injects drugs subcutaneously using a fine jet stream without inserting a needle into the body. The company aims to eliminate medical accidents, infections, and infectious waste.

Injex50 needle-free jet injection system
https://aijexpharma.jp/
Aijex Pharma International, Inc. has developed a needle-free jet injection system called Injex50 (Injex 50) and is working to promote its launch.
This is a subcutaneous injection (an injection that injects a drug into subcutaneous tissue) of a drug solution by means of a fine jet stream, without inserting a needle into the body, thereby reducing needle pain caused by the injection.

Although needle-less injectors have been studied for a long time, their practical application has been hampered by problems of precision and safety. However, Aijex Pharma International, through years of original research and technology created through industry-academia collaboration, has brought the "Injex50" to market.
Last November, as a first approach, the company conducted a test introduction to dentists in Japan through a distributor, and received a positive response. The company has since signed a contract with a new distributor and expects to sell more than 400 sets now that full-scale distribution has begun.
In addition to dentistry, demand is expected to increase for immunizations, local anesthesia, and a wide range of other services.
Aijex Pharma International is implementing fabless management with a focus on R&D and market development, and also plans to create new markets rather than competing with needle and syringe.
In the future, while increasing awareness in Japan, the company aims to expand the system worldwide as a next-generation injection system that can be used in a variety of settings, including vaccines, cosmetic surgery, veterinary medicine, insulin, and fertility treatment, with an eye toward the U.S. and other global markets.
About Aijex Pharma International, Inc.
The company was founded in 2016 by its president, Fukushima, a graduate of a U.S. university with experience managing six companies. Representative Fukushima is currently enrolled in the Graduate School of Integrated Bioscience and Biotechnology at the University of Toyama, while further researching and developing needle-free injections in between his work as president.
The team consists of global management experts and members skilled in medical device sales, and aims to promote the use of needle-free syringes.
| name of company | Aijex Pharma International Ltd. |
| Establishment | June 10, 2016 |
| capital stock | 〒930-0871 Room 302, Toyama City New Industry Support Center, 16 Shimono, Toyama City |
| representative | Masayoshi Fukushima, President and Representative Director |
| Business Overview | Needle-less syringe planning and sales Research and development of needle-free jet injection system |
| uniform resouce locator | https://aijexpharma.jp/ |








